Gruss & Co’s Celgene Corp CELG Stock Holding History

Gruss & Co’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,000	Closed	-$577K	–	49
2018 Q4	$577K	Buy	+9,000	New	+$664K	0.74%	23
2018 Q1	–	Sell	-2,000	Closed	-$209K	–	39
2017 Q4	$209K	Sell	2,000 -1,000	-33%	-$113K	0.2%	30
2017 Q3	$437K	Buy	3,000 +1,000	+50%	+$136K	0.49%	25
2017 Q2	$260K	Hold	2,000	–	–	0.29%	34
2017 Q1	$249K	Hold	2,000	–	–	0.25%	36
2016 Q4	$232K	Hold	2,000	–	–	0.25%	40
2016 Q3	$209K	Buy	+2,000	New	+$216K	0.26%	32
2016 Q2	–	Sell	-2,000	Closed	-$200K	–	43
2016 Q1	$200K	Hold	2,000	–	–	0.27%	33
2015 Q4	$240K	Hold	2,000	–	–	0.32%	35
2015 Q3	$216K	Hold	2,000	–	–	0.34%	29
2015 Q2	$231K	Hold	2,000	–	–	0.2%	39
2015 Q1	$231K	Hold	2,000	–	–	0.25%	34
2014 Q4	$224K	Buy	+2,000	New	+$211K	0.32%	36
2014 Q3	–	Sell	-4,000	Closed	-$344K	–	55
2014 Q2	$344K	Buy	+4,000	New	+$304K	0.39%	41

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gruss & Co's CELG Position: Q1 2019 in Review

Gruss & Co sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 9,000 shares — an estimated $577K sold.

Gruss & Co first reported a position in CELG in Q2 2014 and held it in 14 quarters. The position peaked at $577K in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Gruss & Co reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Gruss & Co sold 9,000 Celgene Corp shares in Q1 2019, an estimated $577K.
Gruss & Co first reported a position in Celgene Corp in Q2 2014 and held it in 14 quarters.
Gruss & Co's Celgene Corp position peaked at $577K in Q4 2018.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Gruss & Co's 13F filing for Q1 2019, filed 10 May 2019.